Kwang Dong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kwang Dong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Daewoong Pharmaceutical Company Limited
sales of 1.03 trillion Korean Won [US$871.56 million]
of which 103%
was Medicine Manufacture&Sale),
Daewoong Company Limited
(1.23 trillion Korean Won [US$1.04 billion]
of which 113%
was Medicinal Manufacturing & Selling), and
Hanmi Pharmaceutical., Company Limited
(1.02 trillion Korean Won [US$858.49 million]
of which 78%
During the year ended December of 2018, sales at
Kwang Dong Pharmaceutical Company Limited were 1.18 trillion Korean Won (US$997.29 million).
increase of 3.4%
versus 2017, when the company's sales were 1.14 trillion Korean Won.
This was the fifth consecutive year of sales increases at Kwang Dong Pharmaceutical Company Limited
(and since 2013, sales have increased a total of 152%).
Sales of Mro saw an increase
that was more than double the company's growth rate: sales were up
7.7% in 2018, from
461.84 billion Korean Won to 497.51 billion Korean Won.
Kwang Dong Pharmaceutical Company Limited also saw significant increases in sales in
Pharmacy Operations (up 5.3% to 238.96 billion Korean Won)
Not all segments of Kwang Dong Pharmaceutical Company Limited experienced an increase in sales in 2018:
sales of Other Segements fell 20.5% to 17.25 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).
Kwang Dong Pharmaceutical Company Limited also experienced decreases in sales in
Food Products Operations (down 0.8% to 458.12 billion Korean Won)